Advanced Cancer Therapeutics (ACT) is leading innovation
within the biotechnology industry. Founded in January 2007,
the company is focused on the discovery and early
development of novel cancer therapeutics as well as selection
for partnership, commercialization and manufacture of the
most promising discoveries. Utilizing its groundbreaking business
arrangement with the James
Graham Brown Cancer Center and the University of Louisville Research
Foundation, ACT will establish exclusive rights to specific
novel therapeutics and fast-track these leading edge discoveries
to the pharmaceutical
industry, and ultimately the patients who need them.
|
